Reinstatement of episodic-like memory in rats by neurokinin-1 receptor antagonism

Neurobiology of Learning and Memory

Volumn 87, Issue 3, 2007, Pages 324-331

  Kart Teke, Emriye ^a   Dere, Ekrem ^a   Brandão, Marcus L ^b   Huston, Joseph P ^a   De Souza Silva, Maria A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acetylcholine; Alzheimer's disease; Cognitive enhancer; Hippocampus; Object memory; SR140333; Stress

Indexed keywords

ACETYLCHOLINE; NEUROKININ 1 RECEPTOR ANTAGONIST; NOLPITANTIUM;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BODY POSTURE; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; EPISODIC MEMORY; HIPPOCAMPUS; LOW DRUG DOSE; MALE; MEMORY DISORDER; NONHUMAN; PSYCHOMOTOR ACTIVITY; RAT; RECEPTOR BLOCKING; STEREOTYPY; STRESS; SYSTEMIC THERAPY; TRANQUILIZING ACTIVITY;

ALZHEIMER DISEASE; ANIMALS; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MEMORY; MOTOR ACTIVITY; PIPERIDINES; PSYCHOMOTOR PERFORMANCE; QUINUCLIDINES; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; STATISTICS, NONPARAMETRIC;

EID: 33846376913     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2006.09.007     Document Type: Article

References (48)

1. Aggleton J.P., and Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behavioral Brain Science 22 (1999) 425-444
2. Alves I.D., Delaroche D., Mouillac B., Salamon Z., Tollin G., Hruby V.J., et al. The two NK-1 binding sites correspond to distinct, independent, and non-interconvertible receptor conformational states as confirmed by plasmon-waveguide resonance spectroscopy. Biochemistry 45 (2006) 5309-5318
3. Bailey S.J., and Jordan C.C. A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon. British Journal of Pharmacology 82 (1984) 441-451
4. Baker K.B., and Kim J.J. Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats. Learning & Memory 9 (2002) 58-65
5. Bradesi S., Eutamene H., Garcia-Villar R., Fioramonti J., and Bueno L. Stress-induced visceral hypersensitivity in female rats is estrogen-dependent and involves tachykinin NK1 receptors. Pain 102 (2003) 227-234
6. Bradesi S., Eutamene H., Fioramonti J., and Bueno L. Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids. Gut 50 (2002) 349-354
7. Corcoran K.A., Desmond T.J., Frey K.A., and Maren S. Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. The Journal of Neuroscience 25 (2005) 8978-8987
8. Dere E., Huston J.P., and De Souza Silva M.A. Integrated Memory for objects, places and temporal order: evidence for episodic-like memory in mice. Neurobiology of Learning and Memory 84 (2005) 214-221
9. Dere E., Huston J.P., and De Souza Silva M.A. Protocol: episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory. Brain Research Protocols 16 (2005) 10-19
10. Emonds-Alt X., Doutremepuich J.D., Heaulme M., Neliat G., Santucci V., Steinberg R., et al. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. European Journal of Pharmacology 250 (1993) 403-413
11. Ennaceur A., Neave N., and Aggleton J.P. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Experimental Brain Research 113 (1997) 509-519
12. Featherstone R.L., Fosbraey P., and Morton I.K. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum. British Journal of Pharmacology 87 (1986) 73-77
13. Harrison S., and Geppetti P. Substance P. International Journal of Biochemistry and Cell Biology 33 (2001) 555-576
14. Hasenöhrl R.U., De Souza Silva M.A., Nikolaus S., Tomaz C., Brandao M.L., Schwarting R.K., et al. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34 (2000) 272-280
15. Hasenöhrl R.U., Jentjens O., De Souza Silva M.A., Tomaz C., and Huston J.P. Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. European Journal of Pharmacology 354 (1998) 123-133
16. Hasselmo M.E., Wyble B.P., and Wallenstein G.V. Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus 6 (1996) 693-708
17. Herpfer I., and Lieb K. Substance P and substance P receptor antagonists in the pathogenesis and treatment of affective disorders. The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry 4 (2003) 56-63
18. Hinson J.P., and Kapas S. Effect of splanchnic nerve section and compensatory adrenal hypertrophy on rat adrenal neuropeptide content. Regulatory Peptides 61 (1996) 105-109
19. Hinson J.P., Purbrick A., Cameron L.A., and Kapas S. The role of neuropeptides in the regulation of adrenal zona fasciculata/reticularis function. Effects of vasoactive intestinal polypeptide, substance P, neuropeptide Y, Met- and Leuenkephalin and neurotensin on corticosterone secretion in the intact perfused rat adrenal gland in situ. Neuropeptides 26 (1994) 391-397
20. Hokfelt T., Pernow B., and Wahren J. Substance P: a pioneer amongst neuropeptides. Journal of Internal Medicine 249 (2001) 27-40
21. Huston J.P., and Hasenöhrl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behavioural Brain Research 66 (1995) 117-127
22. Joels M., Pu Z., Wiegert O., Oitzl M.S., and Krugers H.J. Learning under stress: how does it work?. Trends in Cognitive Sciences 10 (2006) 152-158
23. Jung M., Calassi R., Maruani J., Barnouin M.C., Souilhac J., Poncelet M., et al. Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors. Neuropharmacology 33 (1994) 167-179
24. Kart E., Jocham G., Muller C.P., Schlömer C., Brandao M.L., Huston J.P., et al. Neurokinin-1 receptor antagonism by SR140333: enhanced in vivo ACh in the hippocampus and promnestic post-trial effects. Peptides 25 (2004) 1959-1969
25. Kart-Teke E., De Souza Silva M.A., Huston J.P., and Dere E. Wistar rats show episodic-like memory for unique experiences. Neurobiology of Learning and Memory 85 (2006) 173-182
26. Langosch J.M., Kupferschmid S., Heinen M., Walden J., Herpfer I., Fiebich B.L., et al. Effects of substance P and its antagonist L-733060 on long term potentiation in guinea pig hippocampal slices. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (2005) 315-319
27. Maeno H., Kiyama H., and Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Molecular Brain Research 18 (1993) 43-58
28. Mansikka H., Shiotani M., Winchurch R., and Raja S.N. Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. Anesthesiology 90 (1999) 1643-1649
29. Mantyh P.W., Gates T., Mantyh C.R., and Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. The Journal of Neuroscience 9 (1989) 258-279
30. McLean S. Do substance P and the NK1 receptor have a role in depression and anxiety?. Current Pharmaceutical Design 11 (2005) 1529-1547
31. Mitchell J.B., and Laiacona J. The medial frontal cortex and temporal memory: tests using spontaneous exploratory behaviour in the rat. Behavioral Brain Research 97 (1998) 107-113
32. Morcuende S., Gadd C.A., Peters M., Moss A., Harris E.A., Sheasby A., et al. Increased neurogenesis and brain-derived neurotrophic factor in neurokinin-1 receptor gene knockout mice. European Journal of Neuroscience 18 (2003) 1828-1836
33. Nagel J.A., and Huston J.P. Enhanced inhibitory avoidance learning produced by post-trial injections of substance P into the basal forebrain. Behavioral and Neural Biology 49 (1988) 374-385
34. Nikolaus S., Huston J.P., and Hasenohrl R.U. Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor. European Journal of Pharmacology 370 (1999) 93-99
35. Ogier R., and Raggenbass M. Action of tachykinins in the rat hippocampus: modulation of inhibitory synaptic transmission. European Journal of Neuroscience 17 (2003) 2639-2647
36. Ovsepian S.V., Anwyl R., and Rowan M.J. Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study. European Journal of Neuroscience 20 (2004) 1267-1275
37. Payne J.D., Jackson E.D., Ryan L., Hoscheidt S., Jacobs J.W., and Nadel L. The impact of stress on neutral and emotional aspects of episodic memory. Memory 14 (2006) 1-16
38. Pitcher G.M., and Henry J.L. Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain. Experimental Neurology 186 (2004) 173-197
39. Quartara L., and Maggi C.A. The tachykinin NK1 receptor. Part II: distribution and pathophysiology. Neuropeptides 32 (1998) 1-49
40. Riepe M.W. Cholinergic treatment: what are the early neuropathological targets?. European Journal of Neurology 12 Suppl 3 (2005) 3-9
41. Roozendaal B. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 25 (2000) 213-238
42. Rupniak N.M.J. Substance P (NK1 receptor) antagonists. In: Steckler T., Kalin N.H., and Reul J.M.H.M. (Eds). Handbook of Stress and the Brain. Part 2: Stress: Integrative and Clinical Aspects (2005), Elsevier, Amsterdam 423-435
43. Rupniak N.M.J., Carlson E.J., Webb J.K., Harrison T., Porsolt R.D., Roux S., et al. Comparison of the phenotype of NK1R/ mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behavioural Pharmacology 12 (2001) 497-508
44. Santarelli L., Gobbi G., Debs P.C., Sibille E.L., Blier P., Hen R., et al. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 1912-1917
45. Sarter M., and Parikh V. Choline transporters, cholinergic transmission and cognition. Nature Reviews Neuroscience 6 (2005) 48-56
46. Vargha-Khadem F., Gadian D.G., Watkins K.E., Connelly A., Van Paesschen W., and Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science 277 (1997) 376-380
47. Vaupel R., Jarry H., Schlomer H.T., and Wuttke W. Differential response of substance P-containing subtypes of adrenomedullary cells to different stressors. Endocrinology 123 (1988) 2140-2145
48. Yu Z., Cheng G., Huang X., Li K., and Cao X. Neurokinin-1 receptor antagonist SR140333: a novel type of drug to treat cerebral ischemia. Neuroreport 8 (1997) 2117-2119